Effects of small interfering RNA inhibit class I phosphoinositide 3-kinase on human gastric cancer cells

World Journal of Gastroenterology

Volumn 19, Issue 11, 2013, Pages 1760-1769

  Zhu, Bao Song ^a   Yu, Li Yan ^a   Zhao, Kui ^a   Wu, Yong You ^a   Cheng, Xiao Li ^b   Wu, Yong ^a   Zhong, Feng Yun ^a   Gong, Wei ^a   Chen, Qiang ^a   Xing, Chun Gen ^a  

^a SOOCHOW UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Class I Phosphoinositide 3 kinase; Gastric cancer cells; Rna interference

Indexed keywords

BECLIN 1; MICROTUBULE ASSOCIATED PROTEIN 1; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN BCL 2; PROTEIN P53; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOREACTIVITY; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STOMACH CANCER; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

EID: 84875391503     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i11.1760     Document Type: Article

References (22)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362 [PMID: 16489633]
2. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-1657 [PMID: 12040186 DOI: 10.1126/sci-ence.296.5573.1655]
3. Liu LZ, Zhou XD, Qian G, Shi X, Fang J, Jiang BH. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/ p70S6K1 pathway. Cancer Res 2007; 67: 6325-6332 [PMID: 17616691 DOI: 10.1158/0008-5472.CAN-06-4261]
4. Faried LS, Faried A, Kanuma T, Aoki H, Sano T, Nakazato T, Tamura T, Kuwano H, Minegishi T. Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy. Mol Carcinog 2008; 47: 446-457 [PMID: 18058806 DOI: 10.1002/mc.20402]
5. Yang X, Fraser M, Moll UM, Basak A, Tsang BK. Akt-me-diated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Cancer Res 2006; 66: 3126-3136 [PMID: 16540663 DOI: 10.1158/0008-5472.CAN-05-0425]
6. Faried LS, Faried A, Kanuma T, Sano T, Nakazato T, Tamura T, Kuwano H, Minegishi T. Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy. Oncol Rep 2006; 16: 57-63 [PMID: 16786123]
7. Hou G, Xue L, Lu Z, Fan T, Tian F, Xue Y. An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR. Cancer Lett 2007; 253: 236-248 [PMID: 17360108 DOI: 10.1016/j.canlet.2007.01.026]
8. Lee S, Choi EJ, Jin C, Kim DH. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplifcation contributes to cisplatin resistance in an ovarian cancer cell line. Gynecol Oncol 2005; 97: 26-34 [PMID: 15790433 DOI: 10.1016/j.ygyno.2004.11.051]
9. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4: 988-1004 [PMID: 16341064 DOI: 10.1038/nrd1902]
10. Biederbick A, Kern HF, Elsässer HP. Monodansylcadaverine (MDC) is a specifc in vivo marker for autophagic vacuoles. Eur J Cell Biol 1995; 66: 3-14 [PMID: 7750517]
11. Rashid SF, Moore JS, Walker E, Driver PM, Engel J, Edwards CE, Brown G, Uskokovic MR, Campbell MJ. Syner-gistic growth inhibition of prostate cancer cells by 1 alpha,25 Dihydroxyvitamin D(3) and its 19-nor-hexafuoride analogs in combination with either sodium butyrate or trichostatin A. Oncogene 2001; 20: 1860-1872 [PMID: 11313934 DOI: 10.1038/ sj.onc.1204269]
12. Niemann A, Takatsuki A, Elsässer HP. The lysosomotropic agent monodansylcadaverine also acts as a solvent polarity probe. J Histochem Cytochem 2000; 48: 251-258 [PMID: 10639491 DOI: 10.1177/002215540004800210]
13. Yoshimori T. Autophagy: a regulated bulk degradation process inside cells. Biochem Biophys Res Commun 2004; 313: 453-458 [PMID: 14684184]
14. Moll UM, Zaika A. Nuclear and mitochondrial apoptotic pathways of p53. FEBS Lett 2001; 493: 65-69 [PMID: 11286997 DOI: 10.1016/S0014-5793(01)02284-0]
15. Erster S, Mihara M, Kim RH, Petrenko O, Moll UM. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol Cell Biol 2004; 24: 6728-6741 [PMID: 15254240 DOI: 10.1128/MCB.24.15.6728-6741.2004]
16. Crighton D, Ryan KM. Splicing DNA-damage responses to tumour cell death. Biochim Biophys Acta 2004; 1705: 3-15 [PMID: 15585169 DOI: 10.1142/S1363246904001614]
17. Lum JJ, DeBerardinis RJ, Thompson CB. Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol 2005; 6: 439-448 [PMID: 15928708 DOI: 10.1038/ nrm1660]
18. Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S, Gilliam TC, Levine B. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 1999; 59: 59-65 [PMID: 10395800 DOI: 10.1006/geno.1999.5851]
19. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G, Levine B. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112: 1809-1820 [PMID: 14638851 DOI: 10.1172/JCI200320039]
20. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-939 [PMID: 16179260 DOI: 10.1016/j.cell.2005.07.002]
21. Høyer-Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G, Farkas T, Bianchi K, Fehrenbacher N, Elling F, Rizzuto R, Mathiasen IS, Jäättelä M. Control of macroau- tophagy by calcium, calmodulin-dependent kinase kinase- beta, and Bcl-2. Mol Cell 2007; 25: 193-205 [PMID: 17244528 DOI: 10.1016/j.molcel.2006.12.009]
22. Oberstein A, Jeffrey PD, Shi Y. Crystal structure of the Bcl- XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 2007; 282: 13123-13132 [PMID: 17337444 DOI: 10.1074/jbc.M700492200]